These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2538095)

  • 21. Susceptibility to varicella zoster virus infection in health care workers.
    Gallagher J; Quaid B; Cryan B
    Occup Med (Lond); 1996 Aug; 46(4):289-92. PubMed ID: 8854707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility.
    Steele RW; Coleman MA; Fiser M; Bradsher RW
    Pediatrics; 1982 Oct; 70(4):604-8. PubMed ID: 6289236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospital experience with varicella-zoster virus.
    Krasinski K; Holzman RS; LaCouture R; Florman A
    Infect Control; 1986 Jun; 7(6):312-6. PubMed ID: 3011693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity to varicella zoster virus in children with leukaemia.
    Ndumbe PM; Wheeler K; Chessells JM; Levinsky RJ
    Med Microbiol Immunol; 1988; 177(2):83-9. PubMed ID: 2834625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of specific IGA antibodies to varicella zoster virus by immunoperoxidase assay.
    Haikin H; Sarov I
    J Clin Pathol; 1982 Jun; 35(6):645-9. PubMed ID: 6282941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of historical and serologic immunity to varicella-zoster virus in 373 hospital employees.
    Donowitz LG; Hunt EH; Pugh VG; Farr BM; Hendley JO
    Am J Infect Control; 1987 Oct; 15(5):212-4. PubMed ID: 2823644
    [No Abstract]   [Full Text] [Related]  

  • 31. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
    Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
    Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
    Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
    Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
    J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections.
    Gallo D; Schmidt NJ
    J Clin Microbiol; 1981 Nov; 14(5):539-43. PubMed ID: 6273453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of varicella-zoster virus-specific IgA antibodies in varicella and zoster patients and in healthy adults of various ages by solid-phase radioimmunoassay.
    Levy E; Mosovitz B; Friedman M; Sarov I
    Intervirology; 1983; 20(2-3):123-8. PubMed ID: 6313543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients.
    Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Sundqvist VA; Wahren B
    J Infect Dis; 1986 May; 153(5):840-7. PubMed ID: 3009635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manipulation of the Innate Immune Response by Varicella Zoster Virus.
    Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A
    Front Immunol; 2020; 11():1. PubMed ID: 32038653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of Hospital Policy for Healthcare Workers and Patients Exposed to Varicella-Zoster Virus.
    Kim SH; Park SH; Choi SM; Lee DG
    J Korean Med Sci; 2018 Sep; 33(36):e252. PubMed ID: 30181734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.